Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs), OTHER DEVICES FOR TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS, RANDOMIZED TRIALS (RCTs) AND BTK TREATMENTS
Location: Grand Ballroom East, 3rd Floor
Moderators:Michael S. Conte, MD / Antonio Micari, MD, PhD  
SESSION 26 SCHEDULE
10:16 AM - 10:21 AM Impact And Significance Of Downstream Embolization And Restenosis With Different DCBs
  Presenter(s):Aloke Finn, MD / Renu Virmani, MD  
  View Slides in PDF      
10:22 AM - 10:27 AM DCBs Are Changing The Landscape And Algorithm For Treating Long Complex SFA/Pop Lesions And Minimizing The Need For Stents: Advantages Of Sirolimus vs. Paclitaxel Coatings
  Presenter(s):Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:28 AM - 10:33 AM Update On In.Pact SFA I And II RCTs Show Benefit Of In.Pact (Medtronic) DCBs Persisting And Increasing Over POBA At 4 years With Fem/Pop Lesions
  Presenter(s):John R. Laird, MD / Peter A. Schneider, MD / Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:34 AM - 10:39 AM Update On Persistent Benefit Of Lutonix DCB (Bard/BD) For Fempop Lesions As Shown By A RCT vs. Plain Balloon Angioplasty (POBA): Long Lesions (>14 cm) Were Included
  Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:40 AM - 10:45 AM COMPARE Pilot RCT: 1 Year Results Of A Randomized Comparison Of RANGER DCB vs. IN.PACT DCB In Complex SFA Lesions
  Presenter(s):Dierk Scheinert, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:46 AM - 10:51 AM Update On ILLUMINATE RCTs With Stellarex DCBs (Spectranetics/Philips): 2- And 3-Year Results For SFA/Pop Lesions And ISR Are Equal To Other DCBs: Advantages Over Other DCBs
  Presenter(s):Sean P. Lyden, MD / Timothy M. Sullivan, MD / Thomas Zeller, MD / Stefan Mueller-Huelsbeck, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:52 AM - 10:57 AM Lessons Learned From The In.Pact DCB GLOBAL Registry - Chronic Total Occlusion (CTO) Cohort: How To Make DCBs Work Best With CTOs
  Presenter(s):Marianne Brodmann, MD / Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:58 AM - 11:03 AM In.Pact DCBs Have Equal Benefits When Treating Long SFA/Pop Lesions As When Treating Shorter Lesions
  Presenter(s):Antonio Micari, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:04 AM - 11:11 AM Panel Discussion
Moderator(s): Sean P. Lyden, MD / Giancarlo Biamino, MD, PhD  
11:11 AM - 11:16 AM What Is The Long-Term Durability Of The Benefits Of The Different DCBs: What Is The Value Of Spot Stenting Of Residual Stenoses With DCBs
  Presenter(s):Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:17 AM - 11:22 AM Present Role For DCBs And DESs For SFA Lesions: Updated Treatment Algorithm And How To Deal With Severe Calcification
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:23 AM - 11:28 AM Update On Evaluation Of DCBs: When Are They Worthwhile And Advantages Of Different DCBs
  Presenter(s):Gary M. Ansel, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
DCBS FOR BTK LESIONS
11:29 AM - 11:34 AM Value Of DCBs In BTK And Crural Arteries: Reasons For Past Failures: New Technology, New Results And Promising Future Prospects
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:35 AM - 11:40 AM Value Of Stellarex DCBs (Spectranetics/Philips) In BTK And Infrapopliteal Artery Lesions
  Presenter(s):Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:41 AM - 11:46 AM > 1-Year Safety And Effectiveness Results Of Lutonix DCBs (Bard/BD) For Treating BTK And Crural Artery Lesions: Late Breaking Update And 6-Month Results Of Lutonix Below-The-Knee Global DCB IDE RCT Study
  Presenter(s):Patrick J. Geraghty, MD / Michael K.W. Lichtenberg, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:47 AM - 11:52 AM Update On Value Of The Chocolate Touch (Restrained) DCB (QT Vascular And TriReme Medical): What Makes It Different And 2-Year Results From The ENDURE Trial
  Presenter(s):Gunnar Tepe, MD / D. Christopher Metzger, MD  / Andrew Holden, MBChB / Wei Guo, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26
previous next